P38 activation mediates amyloid-β cytotoxicity

Neurochemical Research

Volumn 30, Issue 6-7, 2005, Pages 791-796

  Zhu, Xiongwei ^a   Mei, Matthew ^a   Lee, Hyoung Gon ^a   Wang, Yang ^a   Han, Jiahuai ^b   Perry, George ^a   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer disease; Amyloid ; Cytotoxicity; Oxidative stress; p38

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AMYLOID BETA PROTEIN[25-35]; MITOGEN ACTIVATED PROTEIN KINASE P38;

ALZHEIMER DISEASE; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DATA ANALYSIS; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMYLOID BETA-PROTEIN; BLOTTING, WESTERN; CELL LINE, TUMOR; ENZYME ACTIVATION; HUMANS; NEUROBLASTOMA; NEURONS; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 26244465743     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-005-6872-x     Document Type: Article

References (41)

1. M. A. Smith 1998 Alzheimer disease Int. Rev. Neurobiol. 42 1 54
2. J. Tsai J. Grutzendler K. Duff W. B. Gan 2004 Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches Nat. Neurosci. 7 1181 1183
3. C. Behl J. B. Davis R. Lesley D. Schubert 1994 Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77 817 827
4. C. A. Rottkamp A. K. Raina X. Zhu E. Gaier A. I. Bush C. S. Atwood M. Chevion G. Perry M. A. Smith 2001 Redox-active iron mediates amyloid-beta toxicity Free Radic. Biol. Med. 30 447 450
5. D. A. Butterfield D. Boyd-Kimball 2004 Amyloid beta-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain Brain Pathol. 14 426 432
6. G. Perry A. Nunomura K. Hirai X. Zhu M. Perez J. Avila R. J. Castellani C. S. Atwood G. Aliev L. M. Sayre A. Takeda M. A. Smith 2002 Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radic Biol Med 33 1475 1479
7. M. A. Smith P. L. Richey Harris L. M. Sayre J. S. Beckman G. Perry 1997 Widespread peroxynitrite-mediated damage in Alzheimer's disease J. Neurosci. 17 2653 2657
8. M. A. Smith R. K. Kutty P. L. Richey S. D. Yan D. Stern G. J. Chader B. Wiggert R. B. Petersen G. Perry 1994 Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease Am. J. Pathol. 145 42 47
9. M. A. Smith K. Hirai K. Hsiao M. A. Pappolla P. L. Harris S. L. Siedlak M. Tabaton G. Perry 1998 Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress J. Neurochem. 70 2212 2215
10. X. Zhu H-G. Lee G. Perry A. K. Raina M. A. Smith 2002 The MAPK Pathways in Alzheimer's Disease NeuroSignals 11 270 281
11. X. Zhu A. K. Raina H. G. Lee G. Casadesus M. A. Smith G. Perry 2004 Oxidative stress signalling in Alzheimer's disease Brain Res. 1000 32 39
12. X. Zhu A. K. Raina G. Perry M. A. Smith 2004 Alzheimer's disease: The two-hit hypothesis Lancet Neurol. 3 219 226
13. G. Perry H. Roder A. Nunomura A. Takeda A. L. Friedlich X. Zhu A. K. Raina N. Holbrook S. L. Siedlak P. L. Harris M. A. Smith 1999 Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation Neuroreport 10 2411 2415
14. X. Zhu C. A. Rottkamp H. Boux A. Takeda G. Perry M. A. Smith 2000 Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease J. Neuropathol. Exp. Neurol. 59 880 888
15. X. Zhu C. A. Rottkamp A. Hartzler Z. Sun A. Takeda H. Boux S. Shimohama G. Perry M. A. Smith 2001 Activation of MKK6, an upstream activator of p38, in Alzheimer's disease J Neurochem 79 311 318
16. X. Zhu A. K. Raina C. A. Rottkamp G. Aliev G. Perry H. Boux M. A. Smith 2001 Activation and redistribution of c-Jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease J. Neurochem. 76 435 441
17. X. Zhu O. Ogawa Y. Wang G. Perry M. A. Smith 2003 JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease J. Neurochem. 85 87 93
18. K. Hensley R. A. Floyd N. Y. Zheng R. Nael K. A. Robinson X. Nguyen Q. N. Pye C. A. Stewart J. Geddes W. R. Markesbery E. Patel G. V. Johnson G. Bing 1999 p38 kinase is activated in the Alzheimer's disease brain J. Neurochem. 72 2053 2058
19. A. Sun M. Liu X. V. Nguyen G. Bing 2003 P38 MAP kinase is activated at early stages in Alzheimer's disease brain Exp. Neurol. 183 394 405
20. J. J. Pei E. Braak H. Braak I. Grundke-Iqbal K. Iqbal B. Winblad R. F. Cowburn 2001 Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration J. Alzheimers Dis. 3 41 48
21. X. Zhu R. J. Castellani A. Takeda A. Nunomura C. S. Atwood G. Perry M. A. Smith 2001 Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: The 'two hit' hypothesis Mech. Ageing Dev. 123 39 46
22. I. Ferrer R. Blanco M. Carmona B. Puig M. Barrachina C. Gomez S. Ambrosio 2001 Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies J. Neural. Transm. 108 1383 1396
23. M. Shoji N. Iwakami S. Takeuchi M. Waragai M. Suzuki I. Kanazawa C. F. Lippa S. Ono H. Okazawa 2000 JNK activation is associated with intracellular beta-amyloid accumulation Brain Res. Mol. Brain Res. 85 221 233
24. A. W. Hartzler X. Zhu S. L. Siedlak R. J. Castellani J. Avila G. Perry M. A. Smith 2002 The p38 pathway is activated in Pick disease and progressive supranuclear palsy: A mechanistic link between mitogenic pathways, oxidative stress, and tau Neurobiol Aging 23 855 859
25. C. M. Troy S. A. Rabacchi Z. Xu A. C. Maroney T. J. Connors M. L. Shelanski L. A. Greene 2001 beta-Amyloid-induced neuronal apoptosis requires c-Jun N-terminal kinase activation J. Neurochem. 77 157 164
26. Y. Morishima Y. Gotoh J. Zieg T. Barrett H. Takano R. Flavell R. J. Davis Y. Shirasaki M. E. Greenberg 2001 Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand J. Neurosci. 21 7551 7560
27. D. Bozyczko-Coyne T. M. O'Kane Z. L. Wu P. Dobrzanski S. Murthy J. L. Vaught R. W. Scott 2001 CEP-1347/KT-7515, an inhibitor of SAPK/JNK pathway activation, promotes survival and blocks multiple events associated with Abeta-induced cortical neuron apoptosis J. Neurochem. 77 849 863
28. W. Wei X. Wang J. W. Kusiak 2002 Signaling events in amyloid beta-peptide-induced neuronal death and insulin-like growth factor I protection J. Biol. Chem. 277 17649 17656
29. W. M. Daniels J. Hendricks R. Salie J. J. Taljaard 2001 The role of the MAP-kinase superfamily in beta-amyloid toxicity Metab. Brain Dis. 16 175 185
30. 2 and 4-hydroxynonenal mediate amyloid beta-induced neuronal apoptosis by activating JNKs and p38MAPK Exp. Neurol. 180 144 155
31. B. Puig T. Gomez-Isla E. Ribe M. Cuadrado B. Torrejon-Escribano E. Dalfo I. Ferrer 2004 Expression of stress-activated kinases c-Jun N-terminal kinase (SAPK/JNK-P) and p38 kinase (p38-P), and tau hyperphosphorylation in neurites surrounding betaA plaques in APP Tg2576 mice Neuropathol. Appl. Neurobiol. 30 491 502
32. M. J. Savage Y. G. Lin J. R. Ciallella D. G. Flood R. W. Scott 2002 Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition J. Neurosci. 22 3376 3385
33. M. G. Giovannini C. Scali C. Prosperi A. Bellucci M. G. Vannucchi S. Rosi G. Pepeu F. Casamenti 2002 Beta-amyloid-induced inflammation and cholinergic hypofunction in the rat brain in vivo: Involvement of the p38MAPK pathway Neurobiol. Dis. 11 257 274
34. S. J. Harper P. LoGrasso 2001 Signalling for survival and death in neurones: The role of stress-activated kinases, JNK and p38 Cell Signal 13 299 310
35. G. J. Brewer J. R. Torricelli E. K. Evege P. J. Price 1993 Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination J Neurosci Res 35 567 576
36. S. Huang Y. Jiang Z. Li E. Nishida P. Mathias S. Lin R. J. Ulevitch G. R. Nemerow J. Han 1997 Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b Immunity 6 739 749
37. S. D. Yan A. Roher M. Chaney B. Zlokovic A. M. Schmidt D. Stern 2000 Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide Biochim. Biophys. Acta 1502 145 157
38. A. L. Peel N. Sorscher J. Y. Kim V. Galvan S. Chen D. E. Bredesen 2004 Tau Phosphorylation in Alzheimer's Disease: Potential involvement of an APP-MAP kinase complex Neuromol. Med. 5 205 218
39. K. Takeda H. Ichijo 2002 Neuronal p38 MAPK signalling: An emerging regulator of cell fate and function in the nervous system Genes Cells 7 1099 1111
40. H. Fillit W. H. Ding L. Buee J. Kalman L. Altstiel B. Lawlor G. Wolf-Klein 1991 Elevated circulating tumor necrosis factor levels in Alzheimer's disease Neurosci. Lett. 129 318 320
41. A. J. Anderson B. J. Cummings C. W. Cotman 1994 Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease: Association with pathology Exp. Neurol. 125 286 295